Comparative proteogenomic analysis of right-sided colon cancer, left-sided colon cancer and rectal cancer reveals distinct mutational profiles

Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer

(2018) Rona Yaeger et al.   CANCER CELL

Multi-omics Approach Reveals Distinct Differences in Left- and Right-Sided Colon Cancer

(2017) Wangxiong Hu et al.   MOLECULAR CANCER RESEARCH

CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC).

(2017) Alan P. Venook et al.   JOURNAL OF CLINICAL ONCOLOGY

Toward a Shared Vision for Cancer Genomic Data

(2016) Robert L. Grossman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Selective targeting of mutant adenomatous polyposis coli (APC) in colorectal cancer

(2016) L. Zhang et al.   Science Translational Medicine

TCPA: a resource for cancer functional proteomics data

(2013) Jun Li et al.   NATURE METHODS

Cancer Genome Landscapes

(2013) B. Vogelstein et al.   SCIENCE

Comprehensive molecular characterization of human colon and rectal cancer

(2012)   NATURE

Cancers of the Colon and Rectum: Identical or Fraternal Twins?

(2012) Theodore S. Hong et al.   Cancer Discovery